What is ADMA Biologics's work in process?

ADMA Biologics (ADMA) reported work in process of $67.53M in Q1 2026.

How has ADMA Biologics's work in process changed year-over-year?

ADMA Biologics's work in process increased by 35.7% year-over-year, from $49.78M to $67.53M.

What is the long-term trend for ADMA Biologics's work in process?

Over 5 years (2020 to 2025), ADMA Biologics's work in process has grown at a 13.8% compound annual growth rate (CAGR), from $30.29M to $57.8M.

What does work in process mean?

Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.

ADMA Biologics ADMA Work in process

Work in process at other companies

AbbottABT

$994M+11.7%

Bio-Rad LaboratoriesBIO

——

AbbVieABBV

——

AmgenAMGN

——

DanaherDHR

——

Charles River LaboratoriesCRL

——

Other financials

Income statement

See full

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's work in process?: ADMA Biologics (ADMA) reported work in process of $67.53M in Q1 2026.
How has ADMA Biologics's work in process changed year-over-year?: ADMA Biologics's work in process increased by 35.7% year-over-year, from $49.78M to $67.53M.
What is the long-term trend for ADMA Biologics's work in process?: Over 5 years (2020 to 2025), ADMA Biologics's work in process has grown at a 13.8% compound annual growth rate (CAGR), from $30.29M to $57.8M.
What does work in process mean?: Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.